Skip to content

Exploring the therapeutic value and cortical function mechanism of rTMS in the treatment of AD psycho-behavioral symptoms based on fNIRs technology

Exploring the therapeutic value and cortical function mechanism of rTMS in the treatment of AD psycho-behavioral symptoms based on fNIRs technology

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053538
Enrollment
Unknown
Registered
2021-11-24
Start date
2021-12-16
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease (AD)

Interventions

BPSD treatment group:TMS+Nootropics
BPSD control group:TMS pseudostimulation+Nootropics
Control group without BPSD:No TMS

Sponsors

Ningbo Kangning Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. In line with the 1984 National Neurology, Language Impairment and Stroke Research Association AD and Related Disorders Association (NINCDS-ADRDA), the diagnostic criteria for probable ''AD''; 2. BEHAVE-AD scale score >= 8 points, MMSE scale score <= 26 points; 3. Hachinski ischemia scale score <4 points; 4. Have not used any antipsychotic drugs within 2 weeks before hospitalization; 5. Inform the family members of various risks that the patient may have during the research and treatment process. The family members are aware of the above risks, agree to join the group and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The patient suffers from disturbance of consciousness, central nervous system infection, stroke, brain tumor and other neurological diseases, and a history of diseases that may limit the use of TMS or medical treatment devices such as placement of cardiac pacemakers, intracranial metal, aneurysm clips, etc. 2. Have a history of addictive substance dependence, such as alcohol, psychoactive substance abuse. 3. Meet other diagnostic criteria of DSM-5 axis. 4. Hypothyroidism, vitamin B12 deficiency, folic acid deficiency; or dementia caused by various dependence and other physical and chemical factors.

Design outcomes

Primary

MeasureTime frame
Neuropsychiatric Inventory, NPI;

Secondary

MeasureTime frame
Hamilton Depression Scale;Alzheimer's Disease Assessment Scale-Cognitive section;Mini-mental State Examination;Hachinski Ischemic Scale;Barthel Index Scale;AD Pathological Behavior Score Scale;Electrophysiological indicators of the brain;Functional near-infrared spectroscopy;

Countries

China

Contacts

Public ContactWu Xiangping

Ningbo Kangning Hospital

wxp029@126.com+86 13780010403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026